INT195431

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.33
First Reported 2006
Last Reported 2006
Negated 0
Speculated 0
Reported most in Abstract
Documents 3
Total Number 3
Disease Relevance 1.86
Pain Relevance 2.45

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

transport (SLC6A2) plasma membrane (SLC6A2) transmembrane transport (SLC6A2)
SLC6A2 (Homo sapiens)
Pain Link Frequency Relevance Heat
Analgesic 12 99.06 Very High Very High Very High
Pain 176 97.68 Very High Very High Very High
Serotonin 10 94.16 High High
Catecholamine 6 88.64 High High
Neurotransmitter 40 82.56 Quite High
monoamine 42 81.88 Quite High
Inflammatory response 1 68.96 Quite High
visual analogue scale 8 5.00 Very Low Very Low Very Low
Dopamine 8 5.00 Very Low Very Low Very Low
Acute pain 6 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Pain 184 97.68 Very High Very High Very High
Cv Unclassified Under Development 11 77.92 Quite High
Increased Venous Pressure Under Development 17 75.84 Quite High
Systemic Inflammatory Response Syndrome 1 69.68 Quite High
Sepsis 4 66.24 Quite High
Shock 11 50.00 Quite Low
Multiple Organ Failure 13 31.04 Quite Low
Nociception 6 5.00 Very Low Very Low Very Low
Disease 5 5.00 Very Low Very Low Very Low
Impacted Tooth 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Analgesic onset time after medication was significantly associated with the norepinephrine transporter gene (SLC6A2).
SLC6A2 Binding (associated) of associated with analgesic
1) Confidence 0.33 Published 2006 Journal Mol Pain Section Abstract Doc Link PMC1543620 Disease Relevance 0.76 Pain Relevance 1.21
Analgesic onset time after medication was significantly associated with the norepinephrine transporter gene (SLC6A2).
norepinephrine transporter Binding (associated) of associated with analgesic
2) Confidence 0.33 Published 2006 Journal Mol Pain Section Abstract Doc Link PMC1543620 Disease Relevance 0.76 Pain Relevance 1.21
Cardiovascular function could not be stabilized adequately by incremental dosages of norepinephrine in one patient randomly assigned to the norepinephrine group, but MAP could be restored with supplementary AVP infusion.
norepinephrine Binding (dosages) of
3) Confidence 0.04 Published 2006 Journal Crit Care Section Body Doc Link PMC1550871 Disease Relevance 0.34 Pain Relevance 0.03

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox